ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AUPH Aurinia Pharmaceuticals Inc

4.9001
0.0301 (0.62%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aurinia Pharmaceuticals Inc AUPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0301 0.62% 4.9001 18:43:37
Open Price Low Price High Price Close Price Previous Close
4.89 4.86 5.01 4.91 4.87
more quote information »

Recent News

Date Time Source Heading
4/16/202409:48BWUPDATE: New Aurinia Presentation Details at the 2024 Bloom..
4/15/202405:00BWAurinia Pharmaceuticals to Release First Quarter Financial..
4/09/202405:00BWAurinia Will Attend 2024 Bloom Burton & Co. Healthcare..
3/07/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:10EDGAR2Form 8-K - Current report
2/29/202407:30BWAurinia Receives Exemptive Relief from Canadian Securities..
2/27/202407:30BWAurinia to Participate in Upcoming Investor Healthcare..
2/22/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:19EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2/15/202405:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202405:06EDGAR2Form 8-K - Current report
2/15/202405:00BWAurinia Discloses 2023 Year-End Financial and Operational..
2/14/202414:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/05/202407:30BWAurinia Pharmaceuticals to Release 2023 Fourth Quarter and..
1/05/202405:02EDGAR2Form 8-K - Current report
1/05/202405:00BWAurinia Provides Preliminary Unaudited Fourth Quarter and..
12/20/202305:00BWAurinia Submits IND Application to US Food & Drug..
11/13/202305:00BWAurinia Pharmaceuticals Announces Collaboration Partner..
11/07/202309:30BWAurinia Presents Breadth of Data from AURORA Clinical..
11/02/202317:00BWAurinia Presents Breadth of Data at ASN 2023 Demonstrating..
11/02/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202305:01EDGAR2Form 8-K - Current report
11/02/202305:00BWAurinia Pharmaceuticals Reports Third Quarter and Nine..
10/26/202314:00BWAurinia Response in Support of 2023 Updated EULAR..
10/19/202309:31BWCORRECTING and REPLACING Aurinia Pharmaceuticals to Release..
10/19/202305:00BWAurinia Pharmaceuticals to Release Third Quarter Financial..
10/13/202311:00BWAurinia Pharmaceuticals Announces Presentations at American..
9/22/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/21/202315:06EDGAR2Form 8-K - Current report
9/21/202305:00BWAurinia Board of Directors Appoints Dr. Robert T. Foster as..
8/21/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/21/202315:11EDGAR2Form 8-K - Current report
8/21/202305:00BWAurinia Appoints Two New Board Directors with Deep..
8/03/202305:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202305:03EDGAR2Form 8-K - Current report
8/03/202305:00BWAurinia Pharmaceuticals Reports Second Quarter and Six..
7/20/202305:00BWAurinia Pharmaceuticals to Release Second Quarter Financial..
7/19/202311:05BWLong Term Phase 3 Data Published in Arthritis & Rheumatology..
7/06/202307:33EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
7/03/202305:06EDGAR2Form 8-K - Current report
6/29/202315:05BWAurinia Board of Directors Announces Exploration of..
6/20/202308:00BWAurinia Showcases Three Oral Presentations for LUPKYNIS®..
6/01/202308:00BWLUPKYNIS® (voclosporin) Achieved Significantly Higher Renal..

Your Recent History

Delayed Upgrade Clock